Previous studies have demonstrated that a soluble urokinase-type plasminogen activator receptor (suPAR) plays an essential function in leukocytes and endothelial homeostasis and, therefore, in the development of coronary heart disease (CHD) and periodontitis. The aim of this study was to analyze the impact of gingival health, periodontitis and CHD on suPAR levels in plasma and saliva and to evaluate suPAR as a biomarker of periodontitis and CHD.
Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor (suPAR) levels
Isola, Gaetano
Primo
Writing – Review & Editing
;Polizzi, Alessandro;Leonardi, RosaliaUltimo
Conceptualization
2020-01-01
Abstract
Previous studies have demonstrated that a soluble urokinase-type plasminogen activator receptor (suPAR) plays an essential function in leukocytes and endothelial homeostasis and, therefore, in the development of coronary heart disease (CHD) and periodontitis. The aim of this study was to analyze the impact of gingival health, periodontitis and CHD on suPAR levels in plasma and saliva and to evaluate suPAR as a biomarker of periodontitis and CHD.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Isola et al JOP 2020 suPAR.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Dimensione
608.28 kB
Formato
Adobe PDF
|
608.28 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
